Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthgrades for Professionals
As a result of COVID-19, many physicians had to provide telemedicine services in a matter of weeks, if not days. A major accomplishment, for sure. But are you getting paid for your hard work? Read on to find out how you can ensure you are being compensated for the work you’ve been doing.
Allergy & Immunology June 22nd 2020
Based on the data from the ATTRACTION-3 clinical trial, the FDA approved nivolumab (Opdivo; BMS) for the treatment of patients with unresectable advanced, recurrent, or metastatic esophageal squamous cell carcinoma (ESCC) who previously received fluoropyrimidine- and platinum-based chemotherapy.
Gastroenterology June 15th 2020
Gastrointestinal and breast cancer sessions were featured on the first day of the virtual conference, highlighting practice-changing results from a multitude of studies, including the HER2CLIMB, MINDACT, and PHERGAIN trials.
Gastroenterology June 8th 2020
The 2020 Healthgrades National Health Index compared 100 markets based on a cross-section of factors that contribute to quality care and personal health. Here are the five cities that rise above the rest – did your city make the list?
Allergy & Immunology June 1st 2020
The New England Journal of Medicine
In this Journal of Clinical Oncology study, anetumab ravtansine yielded manageable safety, tolerability, pharmacokinetics, and clinical activity in a study of 148 heavily pretreated patients with mesothelin-expressing solid tumors.
Gastroenterology May 18th 2020
JAMA Network
A comprehensive guide from the American Medical Association (AMA), which includes information for those who want to support communities severely impacted by COVID-19, including the how and where to volunteer and all things to consider.
Allergy & Immunology April 13th 2020